The Search for a Novel Diagnostic Marker or Therapeutic Target for Gastrointestinal Cancer

نویسندگان

  • Christoph Röcken
  • Andrea Tannapfel
  • Sabine Krüger
  • Tanja Hundertmark
  • Doreen Gärtner
چکیده

s:1. Röcken C, Schneider-Stock R, McGrath S, Roessner A. Identification and characterization of a novelputative oncogene in hepatocarcinogenesis. Pathol Res Pract 2001; 197(5): 369 [Poster: DeutscheGesellschaft für Pathologie Tagung, 2001]2. Schildhaus HU, Schneider-Stock R, McGrath S, Roessner A, Röcken C. Transcription and expressionof CRSS in non-neoplastic mucosa and in carcinomas of the stomach and colon. Pathol Res Pract 2002;198(3): 181 [Poster: Deutsche Gesellschaft für Pathologie Tagung, 2002]3. Röcken C, Carl-McGrath S, Kähne T, Schulz S, Gräntzdörffer I, Mantke R, Roessner A, Lendeckel U.Functional role of dipeptidyl peptidase in hepatocellular carcinomas. [Vortrag: International Conferenceon Dipeptidyl Aminopeptidases, Berlin, 2002]4. Carl-McGrath S, Lendeckel U, Wolter A, Ebert M, Roessner A, Röcken C. Differential expression ofectopeptidases in gastric cancer. Pathol. Res. Pract. 2003; 199: 256 [Vortrag: Deutsche Gesellschaft fürPathologie Tagung, Bamberg, 2003]5. Röcken C, Carl-McGrath S, Gräntzdörffer I, Mantke R, Roessner A, Lendeckel U. Expression ofectopeptidases in fetal liver, focal nodal hyperplasia and hepatocellular carcinomas. Pathol. Res. Pract.2003; 199: 232 [Poster: Deutsche Gesellschaft für Pathologie Tagung, Bamberg, 2003]6. Röcken C, Carl-McGrath S, Kähne T, Schulz S, Gräntzdörffer I, Mantke R, Roessner A, Lendeckel U.Dipeptidyl peptidase IV in hepatocellular carcinomas. Pathol. Res. Pract. 2003; 199: 232 [Poster:Deutsche Gesellschaft für Pathologie Tagung, Bamberg, 2003]7. Carl-McGrath S, Lendeckel U, Wolter A, Ebert M, Roessner A, Röcken C. Differential expression ofthe disintegrin-metalloproteinases ADAM9, ADAM12 and ADAM15 in diffuse-type and intestinal-typegastric cancer. J. Cancer Res. Clin. Oncol. 2004; 130 (S1): OP375 [Vortrag: Deutsche Krebskongress,Berlin, 2004]8. Carl-McGrath S, Schneider-Stock R, Schildhaus HU, Ebert M, Roessner A, Röcken C. The expressionand localisation of gasdermin-like (GSDML) in carcinomas and non-lesional tissues of the liver,stomach, and colon. Z. Gastroenterol. 2005; 43: 2.07 [Poster: Deutsche Arbeitsgemeinschaft zumStudium der Leber Tagung, Ulm, 2005]9. Carl-McGrath S, Chen J, Ebert M, Roessner A, Röcken C. The stem cell marker, Musashi-1 (MSI-1) isexpressed in intestinal-type, but not in diffuse-type gastric cancers. Onkologie 2005; 28 (S2): PS-3[Poster: Intenationale AEK/AIO Kongress der Deutsche Krebsgesellschaft, Würzburg, 2005]10. Carl-McGrath S, Schneider-Stock R, Schildhaus HU, Ebert M, Roessner A, Röcken C. Gasdermin-like(GSDML), a protein of unknown function, is expressed in a subset of the neuroendocrine cells of thegastrointestinal tract. Eur. J. Cell Biol. 2005; 84 (S55): O-61 [Poster: Deutsche Gesellschaft fürZellbiologie Tagung, Heidelberg, 2005]11. Carl-McGrath S, Lendeckel U, Wolter A, Ebert M, Roessner A, Röcken C. Differential Expression ofDPIV in cancer. [Poster: International Conference on Dipeptidyl Aminopeptidases, Magdeburg, 2005]12. Carl-McGrath S, Lendeckel U, Ebert M, Roessner A, Röcken C. The distribution of angiotensin-converting enzyme in gastritis and stomach ulcer may have implications for ulcer healing. Pathol ResPract. 2005;201(3): 202 [Poster: Deutsche Gesellschaft für Pathologie Tagung, Wuppertal, 2005]

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target

Background: Colorectal cancer is the third most common type of aggressive cancers. Chemotherapy, surgery,and radiotherapy are the common therapeutic options for treating this cancer. Due to the adverse side-eff ects of these methods, immunotherapy is considered as an appropriate alternative therapeutic option. Treatment through the application of monoclonal antibodies is considered as a n...

متن کامل

Scenario and future prospects of microRNAs in gastric cancer: A review

Carcinoma of the stomach is one of the major prevalent and principal causes of cancer-related deaths worldwide. Current advancement in technology has improved the understanding of the pathogenesis and pathology of gastric cancers (GC). But, high mortality rates, unfavorable prognosis and lack of clinical predictive biomarkers provide an impetus to investigate novel early diagnostic/prognostic m...

متن کامل

Cancer stem cells: therapeutic targets

Cancer stem cells (CSCs) have been identified as rare cellular populations in many cancers, including leukemia and solid tumors. This minor subpopulation of cancerous cells is immortal tumor-initiating cells which thought to be responsible for cancer initiation, progression, metastasis, recurrence and drug/radiation resistance. Low proliferative rate, high self-renewing capacity, differentiatio...

متن کامل

Identification of a Novel Tumor-Binding Peptide for Lung Cancer Through in-vitro Panning

Tumor-targeted therapies are playing growing roles in cancer research. The exploitation of these powerful therapeutic modalities largely depends on the discovery of tumor-targeting ligands. Phage display has proven a promising high throughput screening tool for the identification of novel specific peptides with high binding affinity to cancer cells. In the present study, we describe the use of ...

متن کامل

Identification of a Novel Tumor-Binding Peptide for Lung Cancer Through in-vitro Panning

Tumor-targeted therapies are playing growing roles in cancer research. The exploitation of these powerful therapeutic modalities largely depends on the discovery of tumor-targeting ligands. Phage display has proven a promising high throughput screening tool for the identification of novel specific peptides with high binding affinity to cancer cells. In the present study, we describe the use of ...

متن کامل

Diagnostic Utility of miRNAs in Cancer

Cancer is the one of most prevalent and leading causes of death in the world. Current ad­vancements in technology improve the understanding of the pathogenesis and pathology of cancers. But, due to enlarging mortality rates, poor prognosis, and lacunae in clinical early predictive biomarkers provide an important momentum to investigate novel early diagnos­tic/prognostic markers and spec...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2006